Table 2.

The relationship between SUA/LAD and Atrial fibrillation.

Men	Unadjusted model				Adjusted model
	Age ≤65 (n = 2,302)		Age >65 (n = 2,430)		Age ≤65 (n = 2,302)		Age >65 (n = 2,430)
	OR (95% CI)	P-value	OR (95% CI)	P-value	OR (95% CI)	P-value	OR (95% CI)	P-value
SUA	1.002 (1.001, 1.004)	0.001	1.020 (1.010, 1.040)	0.017	1.003 (1.001, 1.004)	0.003	1.000 (0.998, 1.001)	0.934
LAEDD	1.229 (1.188, 1.273)	<0.001	1.177 (1.143, 1.212)	<0.001	1.25 (1.206, 1.304)	<0.001	1.189 (1.152, 1.226)	<0.001
Women	Age ≤65 (n = 1,966)		Age >65 (n = 2,920)		Age ≤65 (n = 1,966)		Age >65 (n = 2,920)
	OR (95% CI)	P-value	OR (95% CI)	P-value	OR (95% CI)	P-value	OR (95% CI)	P-value
SUA	1.003 (1.001, 1.005)	0.007	1.001 (1.000, 1.002)	0.090	1.001 (0.999, 1.004)	0.290	1.000 (0.998, 1.001)	0.778
LAEDD	1.227 (1.166, 1.293)	<0.001	1.208 (1.173, 1.245)	<0.001	1.195 (1.134, 1.260)	<0.001	1.212 (1.173, 1.252)	<0.001

Adjusted for age, systolic blood pressure, serum creatinine, smoking, dyslipidemia and diabetes mellitus, statin, ACEI, ARB, CCB, β-blocker.